Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Exchange Rate Effect (2016 - 2025)

Amphastar Pharmaceuticals (AMPH) has 12 years of Exchange Rate Effect data on record, last reported at -$9000.0 in Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 18.18% year-over-year to -$9000.0; the TTM value through Dec 2025 reached $210000.0, up 210.53%, while the annual FY2025 figure was $210000.0, 210.53% up from the prior year.
  • Exchange Rate Effect reached -$9000.0 in Q4 2025 per AMPH's latest filing, up from -$41000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $142000.0 in Q2 2025 and bottomed at -$238000.0 in Q4 2023.
  • Average Exchange Rate Effect over 5 years is -$35250.0, with a median of -$33500.0 recorded in 2022.
  • Peak YoY movement for Exchange Rate Effect: plummeted 1352.63% in 2023, then skyrocketed 847.37% in 2025.
  • A 5-year view of Exchange Rate Effect shows it stood at -$48000.0 in 2021, then skyrocketed by 139.58% to $19000.0 in 2022, then tumbled by 1352.63% to -$238000.0 in 2023, then soared by 95.38% to -$11000.0 in 2024, then increased by 18.18% to -$9000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Exchange Rate Effect were -$9000.0 in Q4 2025, -$41000.0 in Q3 2025, and $142000.0 in Q2 2025.